Besides cryptocurrencies/blockchain technology, the industry that NIA believes has the biggest growth potential is psychedelics.
On September 27th, NIA announced Numinus Wellness (TSXV: NUMI) at $0.285 per share as its #1 favorite psychedelic stock suggestion and one of its Top 5 favorite overall stock suggestions. Yesterday, NUMI hit a new high since our suggestion of $0.85 per share for a gain of 198.25% from NIA's suggestion price in only two months!
NIA has been researching every publicly traded company in the psychedelic space and so far it is only aware of one other high quality small-cap psychedelic company and it is Revive Therapeutics (CSE: RVV) which NIA recently announced as its latest psychedelic stock suggestion at $0.245 per share. Yesterday, RVV closed up to $0.28 per share and is beginning to build momentum. On November 3rd, Oregon voters legalized psilocybin and RVV has its own psilocybin platform technology that allows for therapeutic doses (1-20mg) of psilocybin to be delivered by orally dissolvable thin films.
Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. NIA has been compensated by NUMI USD$30,000 cash for a six-month marketing contract. NIA has been compensated by RVV USD$30,000 cash for a six-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.